Gene therapy cocktail shows promise for tough mesothelioma
Disease control
Completed
This phase 3 trial tested a new approach for malignant pleural mesothelioma, a rare and aggressive cancer of the lung lining. Researchers gave 53 patients a gene therapy (rAd-IFN) injected into the chest cavity, along with the drugs celecoxib and gemcitabine. The goal was to see …
Phase: PHASE3 • Sponsor: Ferring Ventures Limited • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC